Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scienture Holdings (SCNX) Shares Outstanding (2016 - 2025)

Scienture Holdings (SCNX) has disclosed Shares Outstanding for 13 consecutive years, with $40.6 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 364.32% to $40.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $40.6 million through Dec 2025, up 364.32% year-over-year, with the annual reading at $40.6 million for FY2025, 364.32% up from the prior year.
  • Shares Outstanding hit $40.6 million in Q4 2025 for Scienture Holdings, up from $23.1 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $40.6 million in Q4 2025 to a low of $15759.0 in Q3 2023.
  • Historically, Shares Outstanding has averaged $6.4 million across 5 years, with a median of $793764.0 in 2023.
  • Biggest five-year swings in Shares Outstanding: tumbled 98.08% in 2024 and later surged 146687.61% in 2025.
  • Year by year, Shares Outstanding stood at $544430.0 in 2021, then grew by 15.03% to $626247.0 in 2022, then soared by 44.51% to $905008.0 in 2023, then soared by 866.91% to $8.8 million in 2024, then surged by 364.32% to $40.6 million in 2025.
  • Business Quant data shows Shares Outstanding for SCNX at $40.6 million in Q4 2025, $23.1 million in Q3 2025, and $16.1 million in Q2 2025.